StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Saturday morning. The firm issued a buy rating on the stock. MEI Pharma Price Performance MEIP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback